The effects of ACEIs and ARBs on multiple outcomes in type 2 diabetes patients….
Read More »Prevalence of Diabetic Ketoacidosis at Diagnosis
A recent analysis of youth with type 1 or type 2 diabetes shows that the incidence of DKA continues to be high….
Read More »Negative Outcomes Associated with Inter-arm Systolic Blood Pressure Differences in Diabetes Patients
Inter-arm systolic blood pressure differences may be a sign of bad things to come….
Read More »Standard Tests Can Miss Pediatric Diabetic Neuropathy
Noninvasive methods for screening pediatric patients with type 1 diabetes for peripheral diabetic neuropathy (DN) have low sensitivity, according to a systematic review….
Read More »Greatest Contributor to Diabetes: Obesity or Sugar?
Results of a recent large epidemiological study suggest that it is amount of dietary calories from sugar that plays the most pivotal role in diabetes risk….
Read More »STAMPEDE 3 Results: Bariatric Surgery vs. Intensive Medical Therapy
It appears to offer better and more durable control of diabetes than medical therapy….
Read More »Diabetes Medications Are the Most Expensive
Review of 2013 prescriptions by the Express Scripts shows that diabetes medications trounce all others in terms of annual patient spend on traditional medications….
Read More »Lifestyle Changes during Prediabetes Can Reduce Mortality
Not only may an intensive program of diet, exercise, or both delay progression from prediabetes to diabetes, but among women, it may also lower CVD and all-cause mortality….
Read More »Diabetes and CVD Risk with Postpartum Weight Gain
Failure to lose ‘baby weight’ may carry long-term risk for diabetes and heart disease….
Read More »Aleglitazar Does Not Reduce Risk of Recurrent CV Events among Diabetes Patients
The use of aleglitazar does not appear to reduce the risk of cardiovascular events in diabetic patient….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.